Analysis: Krebs Biochemicals & Industries Limited

NSE:KREBSBIO Pharmaceuticals Bulk Drugs Market cap: ₹120 cr

Research report

companyname: Krebs Biochemicals & Industries Limited ticker: KREBSBIO sector: Pharmaceuticals - Active Pharmaceutical Ingredients (APIs) Krebs Biochemicals & Industries Limited (KREBSBIO) is a manufacturer of bulk pharmaceutical ingredients, commonly called APIs. The company operates two multi-purpose manufacturing facilities in Andhra Pradesh: Unit-I at Regadichelika in Nellore district and Unit-II at Kothapalli in Anakapalli district, near Visakhapatnam. As of 31st March 2025, the company emp...

Read the full report →
RS rating: 27 Stage: Stage 1

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Krebs Biochemicals & Industries Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.